Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham, Birmingham, Alabama.
Department of Diabetes & Endocrinology, Michigan State University College of Human Medicine, Grand Rapids, Missouri.
Endocr Pract. 2022 Feb;28(2):179-184. doi: 10.1016/j.eprac.2021.10.006. Epub 2021 Nov 5.
Obesity has been globally recognized as a critically important disease by professional medical organizations, in addition to the World Health Organization and American Medical Association, but health care systems, medical teams, and the public have been slow to embrace this concept.
The American Association of Clinical Endocrinology staff drafted a survey, and 2 endocrinologists independently reviewed the survey's questions and modified the survey instrument. The survey included questions related to practice and patient demographics, awareness about obesity, treatment of obesity, barriers to improving obesity outcomes, digital health, cognitive behavioral therapy, lifestyle medicine, antiobesity medications, weight stigma, and social determinants of health. The survey was emailed to 493 endocrinologists, with 305 (62%) completing the study.
Of the responders, 98% agreed that obesity is a disease, whereas 2% neither agreed nor disagreed. Of the respondents, 53% were familiar with the term "adiposity-based chronic disease" and 13% were certified by the American Board of Obesity Medicine. Of the respondents, 57% used published obesity guidelines as a resource for treating patients with obesity. Most endocrinologists recommended dietary and lifestyle changes, but fewer prescribed an antiobesity medication or recommended bariatric surgery. American Board of Obesity Medicine-certified endocrinologists were more likely to use a multidisciplinary approach.
Self-reported knowledge and practices in the management of obesity highlight the importance of a multimodal approach to obesity and foster collaboration among health care professionals. It is necessary to raise awareness about obesity among clinicians, identify knowledge gaps, and create educational tools to address those gaps.
除世界卫生组织和美国医学协会外，专业医学组织也已将肥胖症视为一种至关重要的疾病，但医疗保健系统、医疗团队和公众对此概念的接受速度缓慢。
美国临床内分泌医师协会工作人员起草了一份调查，由 2 位内分泌学家独立审查调查问题并修改调查工具。调查包括与实践和患者人口统计学、肥胖症意识、肥胖症治疗、改善肥胖症结果的障碍、数字健康、认知行为疗法、生活方式医学、抗肥胖药物、体重耻辱和健康的社会决定因素相关的问题。该调查以电子邮件的形式发送给 493 位内分泌学家，其中 305 位（62%）完成了研究。
在应答者中，98%的人同意肥胖是一种疾病，而 2%的人既不同意也不反对。在受访者中，53%的人熟悉“基于肥胖的慢性疾病”一词，13%的人通过了美国肥胖医学委员会认证。在受访者中，57%的人将已发表的肥胖指南用作治疗肥胖症患者的资源。大多数内分泌学家建议饮食和生活方式改变，但开抗肥胖药物处方或推荐减肥手术的医生较少。通过美国肥胖医学委员会认证的内分泌学家更倾向于采用多学科方法。
肥胖症管理方面的自我报告知识和实践强调了肥胖症多模式方法的重要性，并促进了医疗保健专业人员之间的合作。有必要提高临床医生对肥胖症的认识，发现知识差距，并创建解决这些差距的教育工具。
